These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35743524)

  • 21. Association of genetic variants of hemostatic genes with myocardial infarction in Egyptian patients.
    El-Fattah AAA; Sadik NAH; Sedrak H; Battah A; Nabil M
    Gene; 2018 Jan; 641():212-219. PubMed ID: 29054763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of factor XIII-A Val34Leu polymorphism on myocardial infarction risk: a meta-analysis.
    Chen F; Qiao Q; Xu P; Fan B; Chen Z
    Clin Appl Thromb Hemost; 2014 Nov; 20(8):783-92. PubMed ID: 24042156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The association between factor XIII Val34Leu polymorphism and early myocardial infarction.
    Hancer VS; Diz-Kucukkaya R; Bilge AK; Ozben B; Oncul A; Ergen G; Nalcaci M
    Circ J; 2006 Mar; 70(3):239-42. PubMed ID: 16501286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factor XIII-A subunit Val34Leu polymorphism in fatal atherothrombotic ischemic stroke.
    Shemirani AH; Antalfi B; Pongrácz E; Mezei ZA; Bereczky Z; Csiki Z
    Blood Coagul Fibrinolysis; 2014 Jun; 25(4):364-8. PubMed ID: 24686102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk for early pregnancy loss by factor XIII Val34Leu: the impact of fibrinogen concentration.
    Dossenbach-Glaninger A; van Trotsenburg M; Oberkanins C; Atamaniuk J
    J Clin Lab Anal; 2013 Nov; 27(6):444-9. PubMed ID: 24218126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of the risk of coronary sclerosis/myocardial infarction by the interaction between factor XIII subunit A Val34Leu polymorphism and fibrinogen concentration in the high risk Hungarian population.
    Bereczky Z; Balogh E; Katona E; Pocsai Z; Czuriga I; Széles G; Kárpáti L; Adány R; Edes I; Muszbek L
    Thromb Res; 2007; 120(4):567-73. PubMed ID: 17250879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Val34Leu polymorphism on the activation of the coagulation factor XIII-A.
    Wartiovaara U; Mikkola H; Szôke G; Haramura G; Kárpáti L; Balogh I; Lassila R; Muszbek L; Palotie A
    Thromb Haemost; 2000 Oct; 84(4):595-600. PubMed ID: 11057856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factor XIII Val34Leu polymorphism and recurrent myocardial infarction in patients with coronary artery disease.
    Kreutz RP; Bitar A; Owens J; Desta Z; Breall JA; von der Lohe E; Sinha A; Vatta M; Nystrom P; Jin Y; Flockhart DA
    J Thromb Thrombolysis; 2014 Oct; 38(3):380-7. PubMed ID: 24510702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The inflammatory response is influenced by FXIII VAL 34 LEU polymorphism in a human LPS model.
    Kovar FM; Marsik CL; Jilma B; Mannhalter C; Joukhadar C; Wagner OF; Endler G
    Wien Klin Wochenschr; 2009; 121(15-16):515-9. PubMed ID: 19787322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of factor XIII Val34Leu polymorphism in patients affected by spontaneous subconjunctival hemorrhage.
    Parmeggiani F; Costagliola C; Incorvaia C; Gemmati D; D'Angelo S; Tognazzo S; Scapoli GL; Sebastiani A
    Am J Ophthalmol; 2004 Sep; 138(3):481-4. PubMed ID: 15364237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased coagulation factor XIII activity but not genetic variants of coagulation factors is associated with myocardial infarction in young patients.
    Ambroziak M; Kuryłowicz A; Budaj A
    J Thromb Thrombolysis; 2019 Oct; 48(3):519-527. PubMed ID: 30972713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is the factor XIII 34Val/Leu polymorphism a protective factor for cerebrovascular disease?
    Endler G; Funk M; Haering D; Lalouschek W; Lang W; Mirafzal M; Wagner O; Mannhalter C
    Br J Haematol; 2003 Jan; 120(2):310-4. PubMed ID: 12542492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A common mutation in the gene for coagulation factor XIII-A (VAL34Leu): a risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases.
    Gemmati D; Serino ML; Ongaro A; Tognazzo S; Moratelli S; Resca R; Moretti M; Scapoli GL
    Am J Hematol; 2001 Jul; 67(3):183-8. PubMed ID: 11391716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Turkish population data on the factor XIII Val34Leu,glycoprotein (GP)Ibalpha Kozak and P-selectin glycoprotein ligand 1 (PSGL-1) loci.
    Hancer VS; Diz-Kucukkaya R; Nalcaci M
    Cell Biochem Funct; 2005; 23(1):55-8. PubMed ID: 15386532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure.
    Ariëns RA; Philippou H; Nagaswami C; Weisel JW; Lane DA; Grant PJ
    Blood; 2000 Aug; 96(3):988-95. PubMed ID: 10910914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of the Val34Leu polymorphism in the factor XIII gene in infants with a birth weight below 1500 g.
    Göpel W; Kattner E; Seidenberg J; Kohlmann T; Segerer H; Möller J;
    J Pediatr; 2002 Jun; 140(6):688-92. PubMed ID: 12072871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factor XIII Val34Leu polymorphism is associated with increased factor XIII activation and decreased transcutaneous oxygen readings in patients with diabetic foot ulcers.
    Küper MA; Schüle R; Mayer P; Königsrainer A; Beckert S
    Diabet Med; 2012 Dec; 29(12):1596-9. PubMed ID: 22578139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of Associations Between
    Sarecka-Hujar B; Kopyta I; Skrzypek M
    Clin Appl Thromb Hemost; 2019; 25():1076029619869500. PubMed ID: 31530188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factor XIII A subunit Val34Leu polymorphism in patients suffering atherothrombotic ischemic stroke.
    Shemirani AH; Pongrácz E; Antalfi B; Adány R; Muszbek L
    Thromb Res; 2010 Aug; 126(2):159-62. PubMed ID: 20609463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of factor XIII levels and polymorphisms on the risk of myocardial infarction in young patients.
    Balogh L; Katona É; Mezei ZA; Kállai J; Gindele R; Édes I; Muszbek L; Papp Z; Bereczky Z
    Mol Cell Biochem; 2018 Nov; 448(1-2):199-209. PubMed ID: 29484525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.